- Home
- ARBK vs IGC Comparison
ARBK vs IGC Comparison
Compare ARBK & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBK
- IGC
- Stock Information
- Founded
- ARBK 2017
- IGC 2005
- Country
- ARBK United Kingdom
- IGC United States
- Employees
- ARBK N/A
- IGC N/A
- Industry
- ARBK Finance: Consumer Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- ARBK Finance
- IGC Health Care
- Exchange
- ARBK Nasdaq
- IGC Nasdaq
- Market Cap
- ARBK 39.8M
- IGC 39.8M
- IPO Year
- ARBK 2021
- IGC N/A
- Fundamental
- Price
- ARBK $0.31
- IGC $0.39
- Analyst Decision
- ARBK Hold
- IGC Strong Buy
- Analyst Count
- ARBK 1
- IGC 2
- Target Price
- ARBK N/A
- IGC $4.00
- AVG Volume (30 Days)
- ARBK 3.8M
- IGC 968.4K
- Earning Date
- ARBK 11-19-2025
- IGC 11-14-2025
- Dividend Yield
- ARBK N/A
- IGC N/A
- EPS Growth
- ARBK N/A
- IGC N/A
- EPS
- ARBK N/A
- IGC N/A
- Revenue
- ARBK $24,043,000.00
- IGC $1,327,000.00
- Revenue This Year
- ARBK $183.90
- IGC $3.54
- Revenue Next Year
- ARBK $26.78
- IGC $15.12
- P/E Ratio
- ARBK N/A
- IGC N/A
- Revenue Growth
- ARBK N/A
- IGC 24.95
- 52 Week Low
- ARBK $0.15
- IGC $0.25
- 52 Week High
- ARBK $1.55
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- ARBK 39.41
- IGC 46.37
- Support Level
- ARBK $0.34
- IGC $0.38
- Resistance Level
- ARBK $0.39
- IGC $0.45
- Average True Range (ATR)
- ARBK 0.06
- IGC 0.03
- MACD
- ARBK -0.03
- IGC -0.00
- Stochastic Oscillator
- ARBK 4.38
- IGC 36.53
About ARBK Argo Blockchain plc
Argo Blockchain PLC is a blockchain technology company focused on the large-scale mining of Bitcoin. It mines bitcoin using purpose-built computers (or mining machines) to solve complex cryptographic algorithms on the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company acquires and deploys mining technology solutions in North American facilities that utilize predominantly renewable and inexpensive electricity.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.